Teva announces pricing and early acceptance results of its debt tender offer

Tel aviv, israel, june 03, 2025 (globe newswire) -- teva pharmaceutical industries ltd. (nyse and tase: teva) (“teva”) announced today the pricing and early acceptance results of its previously announced tender offers (the “offers”) to purchase for cash the outstanding notes issued by finance subsidiaries of teva and guaranteed by teva of the series described in the table below (the “notes”) upon the terms of, and subject to the conditions as set out in, the offer to purchase, dated may 19, 2025 (the “offer to purchase”). capitalized terms used in this announcement but not otherwise defined shall have the meanings given to them in the offer to purchase.
TEVA Ratings Summary
TEVA Quant Ranking